NUI Galway Study on Bipolar Disorder

HRB Clinical Research Facility, Galway
Áis Taighde Chliniciúil HRB, Gaillimh

A team at NUI Galway are conducting a clinical trial study on bipolar disorder.

Nature of the study

SCOPE-BD is a randomised controlled trial investigating if IV Scopolamine (Hyoscine) has a rapid treatment effect for individuals with Bipolar Disorder experiencing a depressive episode.


In order to take part you need to have a diagnosis of bipolar disorder, be at least 18 years of age and are currently experiencing a depressive episode.

More Details

If you or your patient would like to participate or receive more information, please email:
Ruán Kane
Cerena Miravalles
• (PI) Dr. Brian Hallahan

Or call/text the study team directly on: 086-0081175 (Ruán/Cerena)

Sign up to our newsletter for the latest updates

Translate »